One Political Plaza - Home of politics
Home Active Topics Newest Pictures Search Login Register
Main
The Left’s Ugly Reaction to Hydroxychloroquine
Page 1 of 4 next> last>>
Apr 8, 2020 11:13:18   #
eagleye13 Loc: Fl
 
The Left’s Ugly Reaction to Hydroxychloroquine

‘While knee-jerk anti-Trumpism is expected, the angry obsession over the president’s championing of hydroxychloroquine is uniquely ugly.


For one thing, and I realize this might be difficult for some people to comprehend, it’s plausible, even likely, that Trump advocates for chloroquine because he is legitimately optimistic that a therapeutic answer might help Americans. Even if you feel he’s being reckless when speaking about the drug, you can accept that his intentions are good.


It’s also possible that Trump is hopeful about hydroxychloroquine because he thinks it will help his ree******n. Desiring an outcome that benefits the vast majority of Americans, but also benefits you, is a perfectly sound moral position. Hoping for negative outcomes to strengthen your partisan position, on the other hand, is pretty nefarious.


In any event, the crack team at the New York Times thinks it’s unfurled the mystery. “As of last year,” reports the paper, “Mr. Trump reported that his three family trusts each had investments in a Dodge & Cox mutual fund, whose largest holding was in Sanofi.”


As far as we know, Trump probably owns less than $100 of Sanofi stock in one of his mutual funds. If things go well, say he triples his position, Trump will be taking in upwards of $300. Art of the Deal, indeed.’



The Left’s Ugly Reaction to Hydroxychloroquine

David Harsanyi -- April 8, 2020


https://www.nationalreview.com/2020/04/the-lefts-ugly-reaction-to-hydroxychloroquine/

The idea that he is promoting the drug to boost the price of a mutual fund in which he owns shares is perhaps the most ludicrous conspiracy theory yet.

A widely shared, four-person-bylined, “wow”-provoking New York Times story today informs us that Donald Trump is personally benefiting from his “aggressive advocacy” of the anti-malaria drug hydroxychloroquine because he owns stock in one of the companies that manufacture the drug.

The story might be one of the most ridiculous articles published by mainstream media in the Trump era — though, admittedly, the field is highly competitive. But while knee-jerk anti-Trumpism is expected, the angry obsession over the president’s championing of hydroxychloroquine is uniquely ugly.

For one thing, and I realize this might be difficult for some people to comprehend, it’s plausible, even likely, that Trump advocates for chloroquine because he is legitimately optimistic that a therapeutic answer might help Americans. Even if you feel he’s being reckless when speaking about the drug, you can accept that his intentions are good.

It’s also possible that Trump is hopeful about hydroxychloroquine because he thinks it will help his ree******n. Desiring an outcome that benefits the vast majority of Americans, but also benefits you, is a perfectly sound moral position. Hoping for negative outcomes to strengthen your partisan position, on the other hand, is pretty nefarious.

In any event, the crack team at the New York Times thinks it’s unfurled the mystery. “As of last year,” reports the paper, “Mr. Trump reported that his three family trusts each had investments in a Dodge & Cox mutual fund, whose largest holding was in Sanofi.”

As far as we know, Trump probably owns less than $100 of Sanofi stock in one of his mutual funds. If things go well, say he triples his position, Trump will be taking in upwards of $300. Art of the Deal, indeed.

Though it’s unlikely. Sanofi is a French drugmaker that produces the hydroxychloroquine-label Plaquenil. The drug, however, isn’t patented, it isn’t particularly difficult to manufacture, and there are a bunch of giant pharma companies around the world already ramping up production of generic versions. Sanofi is less likely to benefit than Novartis or Bayer (check everyone’s mutual funds, pronto!).

So cunning is Trump’s scheme to spike his $1,000 mutual-fund position that he called India’s prime minister, Narendra Modi, this week and convinced him to lift a ban and start exporting even more generic hydroxychloroquine to the United States.

The Left simply can’t accept that a Republican acts in good faith. If they’re not hiding some devious self-serving motivation, they’re under the thumb of a foreign power or a shadowy industry. If it’s not Big Oil leading George Bush into Iraq, it’s Mitt Romney trying to hand the country to his buddies at Bain Capital.

Working from this predetermined position, reporters are sure that Trump, who they think became president to fill the rooms in his D.C. hotel, isn’t merely peddling hope for hope’s sake alone.

All of this is just fodder for the screeching partisan minions, nothing else. If there were a healthy, functioning fourth column, a piece like this would never run. Can you imagine any major publication running a piece linking Barack Obama’s praise of GM’s heavily subsidized electric-car manufacturing to a thousand bucks in a mutual fund?

Nor should it escape your attention that the New York Times will assign four reporters to write an amateurish hit job, but not a single one to mention serious rape allegations against the leading Democratic Party p**********l candidate by a former staffer.

When Trump first mentioned hydroxychloroquine, reporters scoured the world to find overdose cases so they could claim the president had blood on his hands. When that effort came up short, they clutched pearls after some nitwit couple thought it wise to ingest fish-tank cleaning liquid. Now this.

Hydroxychloroquine is a prescription drug, not a pill that Americans can buy in bulk at the local Walmart and hoard in their closest and pop prophylactically each day. Media keeps asserting that Trump is “ignoring the experts.” Well, the president didn’t induce South Korean doctors to use hydroxychloroquine. He didn’t induce Indian doctors to use it. I assume American doctors who are now “off-labeling” the drug to patients have some medical reasons behind their thinking.

If doctors think it’s promising to look at it as a way to mitigate symptoms, why shouldn’t they go for it? It might help. It might not. Maybe another drug or treatment no one is talking about will emerge. There is nothing wrong with offering hope. Americans aren’t children, even if our media treats them as such.

(You don’t need to send me angry emails detailing all the downsides of championing potential drugs already in use for other diseases. One of my children takes hydroxychloroquine to help mitigate a dangerous autoimmune condition. I’ve already had to work hard to track down hydroxychloroquine because we live in a world with unethical hospitals and doctors who hoard it. Believe it or not, they’d still be doing it if the president hadn’t ever mentioned it, because they believe it holds promise.)

Reply
Apr 8, 2020 11:23:59   #
Liberty Tree
 
eagleye13 wrote:
The Left’s Ugly Reaction to Hydroxychloroquine

‘While knee-jerk anti-Trumpism is expected, the angry obsession over the president’s championing of hydroxychloroquine is uniquely ugly.


For one thing, and I realize this might be difficult for some people to comprehend, it’s plausible, even likely, that Trump advocates for chloroquine because he is legitimately optimistic that a therapeutic answer might help Americans. Even if you feel he’s being reckless when speaking about the drug, you can accept that his intentions are good.


It’s also possible that Trump is hopeful about hydroxychloroquine because he thinks it will help his ree******n. Desiring an outcome that benefits the vast majority of Americans, but also benefits you, is a perfectly sound moral position. Hoping for negative outcomes to strengthen your partisan position, on the other hand, is pretty nefarious.


In any event, the crack team at the New York Times thinks it’s unfurled the mystery. “As of last year,” reports the paper, “Mr. Trump reported that his three family trusts each had investments in a Dodge & Cox mutual fund, whose largest holding was in Sanofi.”


As far as we know, Trump probably owns less than $100 of Sanofi stock in one of his mutual funds. If things go well, say he triples his position, Trump will be taking in upwards of $300. Art of the Deal, indeed.’



The Left’s Ugly Reaction to Hydroxychloroquine

David Harsanyi -- April 8, 2020


https://www.nationalreview.com/2020/04/the-lefts-ugly-reaction-to-hydroxychloroquine/

The idea that he is promoting the drug to boost the price of a mutual fund in which he owns shares is perhaps the most ludicrous conspiracy theory yet.

A widely shared, four-person-bylined, “wow”-provoking New York Times story today informs us that Donald Trump is personally benefiting from his “aggressive advocacy” of the anti-malaria drug hydroxychloroquine because he owns stock in one of the companies that manufacture the drug.

The story might be one of the most ridiculous articles published by mainstream media in the Trump era — though, admittedly, the field is highly competitive. But while knee-jerk anti-Trumpism is expected, the angry obsession over the president’s championing of hydroxychloroquine is uniquely ugly.

For one thing, and I realize this might be difficult for some people to comprehend, it’s plausible, even likely, that Trump advocates for chloroquine because he is legitimately optimistic that a therapeutic answer might help Americans. Even if you feel he’s being reckless when speaking about the drug, you can accept that his intentions are good.

It’s also possible that Trump is hopeful about hydroxychloroquine because he thinks it will help his ree******n. Desiring an outcome that benefits the vast majority of Americans, but also benefits you, is a perfectly sound moral position. Hoping for negative outcomes to strengthen your partisan position, on the other hand, is pretty nefarious.

In any event, the crack team at the New York Times thinks it’s unfurled the mystery. “As of last year,” reports the paper, “Mr. Trump reported that his three family trusts each had investments in a Dodge & Cox mutual fund, whose largest holding was in Sanofi.”

As far as we know, Trump probably owns less than $100 of Sanofi stock in one of his mutual funds. If things go well, say he triples his position, Trump will be taking in upwards of $300. Art of the Deal, indeed.

Though it’s unlikely. Sanofi is a French drugmaker that produces the hydroxychloroquine-label Plaquenil. The drug, however, isn’t patented, it isn’t particularly difficult to manufacture, and there are a bunch of giant pharma companies around the world already ramping up production of generic versions. Sanofi is less likely to benefit than Novartis or Bayer (check everyone’s mutual funds, pronto!).

So cunning is Trump’s scheme to spike his $1,000 mutual-fund position that he called India’s prime minister, Narendra Modi, this week and convinced him to lift a ban and start exporting even more generic hydroxychloroquine to the United States.

The Left simply can’t accept that a Republican acts in good faith. If they’re not hiding some devious self-serving motivation, they’re under the thumb of a foreign power or a shadowy industry. If it’s not Big Oil leading George Bush into Iraq, it’s Mitt Romney trying to hand the country to his buddies at Bain Capital.

Working from this predetermined position, reporters are sure that Trump, who they think became president to fill the rooms in his D.C. hotel, isn’t merely peddling hope for hope’s sake alone.

All of this is just fodder for the screeching partisan minions, nothing else. If there were a healthy, functioning fourth column, a piece like this would never run. Can you imagine any major publication running a piece linking Barack Obama’s praise of GM’s heavily subsidized electric-car manufacturing to a thousand bucks in a mutual fund?

Nor should it escape your attention that the New York Times will assign four reporters to write an amateurish hit job, but not a single one to mention serious rape allegations against the leading Democratic Party p**********l candidate by a former staffer.

When Trump first mentioned hydroxychloroquine, reporters scoured the world to find overdose cases so they could claim the president had blood on his hands. When that effort came up short, they clutched pearls after some nitwit couple thought it wise to ingest fish-tank cleaning liquid. Now this.

Hydroxychloroquine is a prescription drug, not a pill that Americans can buy in bulk at the local Walmart and hoard in their closest and pop prophylactically each day. Media keeps asserting that Trump is “ignoring the experts.” Well, the president didn’t induce South Korean doctors to use hydroxychloroquine. He didn’t induce Indian doctors to use it. I assume American doctors who are now “off-labeling” the drug to patients have some medical reasons behind their thinking.

If doctors think it’s promising to look at it as a way to mitigate symptoms, why shouldn’t they go for it? It might help. It might not. Maybe another drug or treatment no one is talking about will emerge. There is nothing wrong with offering hope. Americans aren’t children, even if our media treats them as such.

(You don’t need to send me angry emails detailing all the downsides of championing potential drugs already in use for other diseases. One of my children takes hydroxychloroquine to help mitigate a dangerous autoimmune condition. I’ve already had to work hard to track down hydroxychloroquine because we live in a world with unethical hospitals and doctors who hoard it. Believe it or not, they’d still be doing it if the president hadn’t ever mentioned it, because they believe it holds promise.)
The Left’s Ugly Reaction to Hydroxychloroquine br ... (show quote)


The left does not want a cure. They want more to die just so they can blame it on Trump.

Reply
Apr 8, 2020 11:46:58   #
eagleye13 Loc: Fl
 
Liberty Tree wrote:
The left does not want a cure. They want more to die just so they can blame it on Trump.


Yep!

Just watch MSNBC to clarify that.

Reply
 
 
Apr 8, 2020 12:06:31   #
Lonewolf
 
Liberty Tree wrote:
The left does not want a cure. They want more to die just so they can blame it on Trump.


Not true its well documented that trump d**gged his feet and downplayed this whole thing.
You cannot take his words or inactions back there now history.
Trump ,Hannity and Tucker and rush are murders .

Reply
Apr 8, 2020 13:23:11   #
lpnmajor Loc: Arkansas
 
eagleye13 wrote:
The Left’s Ugly Reaction to Hydroxychloroquine

‘While knee-jerk anti-Trumpism is expected, the angry obsession over the president’s championing of hydroxychloroquine is uniquely ugly.


For one thing, and I realize this might be difficult for some people to comprehend, it’s plausible, even likely, that Trump advocates for chloroquine because he is legitimately optimistic that a therapeutic answer might help Americans. Even if you feel he’s being reckless when speaking about the drug, you can accept that his intentions are good.


It’s also possible that Trump is hopeful about hydroxychloroquine because he thinks it will help his ree******n. Desiring an outcome that benefits the vast majority of Americans, but also benefits you, is a perfectly sound moral position. Hoping for negative outcomes to strengthen your partisan position, on the other hand, is pretty nefarious.


In any event, the crack team at the New York Times thinks it’s unfurled the mystery. “As of last year,” reports the paper, “Mr. Trump reported that his three family trusts each had investments in a Dodge & Cox mutual fund, whose largest holding was in Sanofi.”


As far as we know, Trump probably owns less than $100 of Sanofi stock in one of his mutual funds. If things go well, say he triples his position, Trump will be taking in upwards of $300. Art of the Deal, indeed.’



The Left’s Ugly Reaction to Hydroxychloroquine

David Harsanyi -- April 8, 2020


https://www.nationalreview.com/2020/04/the-lefts-ugly-reaction-to-hydroxychloroquine/

The idea that he is promoting the drug to boost the price of a mutual fund in which he owns shares is perhaps the most ludicrous conspiracy theory yet.

A widely shared, four-person-bylined, “wow”-provoking New York Times story today informs us that Donald Trump is personally benefiting from his “aggressive advocacy” of the anti-malaria drug hydroxychloroquine because he owns stock in one of the companies that manufacture the drug.

The story might be one of the most ridiculous articles published by mainstream media in the Trump era — though, admittedly, the field is highly competitive. But while knee-jerk anti-Trumpism is expected, the angry obsession over the president’s championing of hydroxychloroquine is uniquely ugly.

For one thing, and I realize this might be difficult for some people to comprehend, it’s plausible, even likely, that Trump advocates for chloroquine because he is legitimately optimistic that a therapeutic answer might help Americans. Even if you feel he’s being reckless when speaking about the drug, you can accept that his intentions are good.

It’s also possible that Trump is hopeful about hydroxychloroquine because he thinks it will help his ree******n. Desiring an outcome that benefits the vast majority of Americans, but also benefits you, is a perfectly sound moral position. Hoping for negative outcomes to strengthen your partisan position, on the other hand, is pretty nefarious.

In any event, the crack team at the New York Times thinks it’s unfurled the mystery. “As of last year,” reports the paper, “Mr. Trump reported that his three family trusts each had investments in a Dodge & Cox mutual fund, whose largest holding was in Sanofi.”

As far as we know, Trump probably owns less than $100 of Sanofi stock in one of his mutual funds. If things go well, say he triples his position, Trump will be taking in upwards of $300. Art of the Deal, indeed.

Though it’s unlikely. Sanofi is a French drugmaker that produces the hydroxychloroquine-label Plaquenil. The drug, however, isn’t patented, it isn’t particularly difficult to manufacture, and there are a bunch of giant pharma companies around the world already ramping up production of generic versions. Sanofi is less likely to benefit than Novartis or Bayer (check everyone’s mutual funds, pronto!).

So cunning is Trump’s scheme to spike his $1,000 mutual-fund position that he called India’s prime minister, Narendra Modi, this week and convinced him to lift a ban and start exporting even more generic hydroxychloroquine to the United States.

The Left simply can’t accept that a Republican acts in good faith. If they’re not hiding some devious self-serving motivation, they’re under the thumb of a foreign power or a shadowy industry. If it’s not Big Oil leading George Bush into Iraq, it’s Mitt Romney trying to hand the country to his buddies at Bain Capital.

Working from this predetermined position, reporters are sure that Trump, who they think became president to fill the rooms in his D.C. hotel, isn’t merely peddling hope for hope’s sake alone.

All of this is just fodder for the screeching partisan minions, nothing else. If there were a healthy, functioning fourth column, a piece like this would never run. Can you imagine any major publication running a piece linking Barack Obama’s praise of GM’s heavily subsidized electric-car manufacturing to a thousand bucks in a mutual fund?

Nor should it escape your attention that the New York Times will assign four reporters to write an amateurish hit job, but not a single one to mention serious rape allegations against the leading Democratic Party p**********l candidate by a former staffer.

When Trump first mentioned hydroxychloroquine, reporters scoured the world to find overdose cases so they could claim the president had blood on his hands. When that effort came up short, they clutched pearls after some nitwit couple thought it wise to ingest fish-tank cleaning liquid. Now this.

Hydroxychloroquine is a prescription drug, not a pill that Americans can buy in bulk at the local Walmart and hoard in their closest and pop prophylactically each day. Media keeps asserting that Trump is “ignoring the experts.” Well, the president didn’t induce South Korean doctors to use hydroxychloroquine. He didn’t induce Indian doctors to use it. I assume American doctors who are now “off-labeling” the drug to patients have some medical reasons behind their thinking.

If doctors think it’s promising to look at it as a way to mitigate symptoms, why shouldn’t they go for it? It might help. It might not. Maybe another drug or treatment no one is talking about will emerge. There is nothing wrong with offering hope. Americans aren’t children, even if our media treats them as such.

(You don’t need to send me angry emails detailing all the downsides of championing potential drugs already in use for other diseases. One of my children takes hydroxychloroquine to help mitigate a dangerous autoimmune condition. I’ve already had to work hard to track down hydroxychloroquine because we live in a world with unethical hospitals and doctors who hoard it. Believe it or not, they’d still be doing it if the president hadn’t ever mentioned it, because they believe it holds promise.)
The Left’s Ugly Reaction to Hydroxychloroquine br ... (show quote)


What do you think trump truly understands about that drug, or any drug, or the v***s? Diddly squat, that's what. He gets his info from fringe websites at 3 am, then sleeps through his daily briefings by people who DO know what the *#$$% they're talking about.

Reply
Apr 8, 2020 15:43:37   #
eagleye13 Loc: Fl
 
lpnmajor wrote:
What do you think trump truly understands about that drug, or any drug, or the v***s? Diddly squat, that's what. He gets his info from fringe websites at 3 am, then sleeps through his daily briefings by people who DO know what the *#$$% they're talking about.


Really!??
Just read the first 3 paragraphs!

"The idea that he is promoting the drug to boost the price of a mutual fund in which he owns shares is perhaps the most ludicrous conspiracy theory yet.

A widely shared, four-person-bylined, “wow”-provoking New York Times story today informs us that Donald Trump is personally benefiting from his “aggressive advocacy” of the anti-malaria drug hydroxychloroquine because he owns stock in one of the companies that manufacture the drug.

The story might be one of the most ridiculous articles published by mainstream media in the Trump era — though, admittedly, the field is highly competitive. But while knee-jerk anti-Trumpism is expected, the angry obsession over the president’s championing of hydroxychloroquine is uniquely ugly."

Your weak positions will be reflected in Trump's ree******n.

Reply
Apr 8, 2020 16:01:42   #
woodguru
 
eagleye13 wrote:


This should be called the right's ignorant response...

This has known side effects, which means it has a value only in severe enough cases that the risks out weigh the potential benefits.

In the limited trials done it was no miracle cure, it was hard to determine how many people would have recovered without it, and the words "opted out early" were not spelled out as died.

It is being tried in New York on hospitalized cases, and we will be hearing more about it.

This is at best something to be used under medical supervision, not as a prophylactic simply to keep c****av***s away. Most people live through c****av***s, so the idea of exposing yourself to known risks to head off also known risks that haven't occurred is truly silly and ignorance based. Rather than have a run on this leave it for clinical situations. People are better off taking zinc and perhaps quinine water, otherwise known as tonic water. Zinc knocks the crap out of colds and flu and chances are it will do the same thing to this.

Reply
 
 
Apr 8, 2020 16:45:56   #
eagleye13 Loc: Fl
 
Lonewolf wrote:
Not true its well documented that trump d**gged his feet and downplayed this whole thing.
You cannot take his words or inactions back there now history.
Trump ,Hannity and Tucker and rush are murders .


C****a V***s info
Left wants you to believe c****av***s is Trump's fault
The Timeline:
https://www.youtube.com/watch?v=wbqZyapMgzY

Reply
Apr 9, 2020 07:25:44   #
Big Kahuna
 
eagleye13 wrote:
The Left’s Ugly Reaction to Hydroxychloroquine

‘While knee-jerk anti-Trumpism is expected, the angry obsession over the president’s championing of hydroxychloroquine is uniquely ugly.


For one thing, and I realize this might be difficult for some people to comprehend, it’s plausible, even likely, that Trump advocates for chloroquine because he is legitimately optimistic that a therapeutic answer might help Americans. Even if you feel he’s being reckless when speaking about the drug, you can accept that his intentions are good.


It’s also possible that Trump is hopeful about hydroxychloroquine because he thinks it will help his ree******n. Desiring an outcome that benefits the vast majority of Americans, but also benefits you, is a perfectly sound moral position. Hoping for negative outcomes to strengthen your partisan position, on the other hand, is pretty nefarious.


In any event, the crack team at the New York Times thinks it’s unfurled the mystery. “As of last year,” reports the paper, “Mr. Trump reported that his three family trusts each had investments in a Dodge & Cox mutual fund, whose largest holding was in Sanofi.”


As far as we know, Trump probably owns less than $100 of Sanofi stock in one of his mutual funds. If things go well, say he triples his position, Trump will be taking in upwards of $300. Art of the Deal, indeed.’



The Left’s Ugly Reaction to Hydroxychloroquine

David Harsanyi -- April 8, 2020


https://www.nationalreview.com/2020/04/the-lefts-ugly-reaction-to-hydroxychloroquine/

The idea that he is promoting the drug to boost the price of a mutual fund in which he owns shares is perhaps the most ludicrous conspiracy theory yet.

A widely shared, four-person-bylined, “wow”-provoking New York Times story today informs us that Donald Trump is personally benefiting from his “aggressive advocacy” of the anti-malaria drug hydroxychloroquine because he owns stock in one of the companies that manufacture the drug.

The story might be one of the most ridiculous articles published by mainstream media in the Trump era — though, admittedly, the field is highly competitive. But while knee-jerk anti-Trumpism is expected, the angry obsession over the president’s championing of hydroxychloroquine is uniquely ugly.

For one thing, and I realize this might be difficult for some people to comprehend, it’s plausible, even likely, that Trump advocates for chloroquine because he is legitimately optimistic that a therapeutic answer might help Americans. Even if you feel he’s being reckless when speaking about the drug, you can accept that his intentions are good.

It’s also possible that Trump is hopeful about hydroxychloroquine because he thinks it will help his ree******n. Desiring an outcome that benefits the vast majority of Americans, but also benefits you, is a perfectly sound moral position. Hoping for negative outcomes to strengthen your partisan position, on the other hand, is pretty nefarious.

In any event, the crack team at the New York Times thinks it’s unfurled the mystery. “As of last year,” reports the paper, “Mr. Trump reported that his three family trusts each had investments in a Dodge & Cox mutual fund, whose largest holding was in Sanofi.”

As far as we know, Trump probably owns less than $100 of Sanofi stock in one of his mutual funds. If things go well, say he triples his position, Trump will be taking in upwards of $300. Art of the Deal, indeed.

Though it’s unlikely. Sanofi is a French drugmaker that produces the hydroxychloroquine-label Plaquenil. The drug, however, isn’t patented, it isn’t particularly difficult to manufacture, and there are a bunch of giant pharma companies around the world already ramping up production of generic versions. Sanofi is less likely to benefit than Novartis or Bayer (check everyone’s mutual funds, pronto!).

So cunning is Trump’s scheme to spike his $1,000 mutual-fund position that he called India’s prime minister, Narendra Modi, this week and convinced him to lift a ban and start exporting even more generic hydroxychloroquine to the United States.

The Left simply can’t accept that a Republican acts in good faith. If they’re not hiding some devious self-serving motivation, they’re under the thumb of a foreign power or a shadowy industry. If it’s not Big Oil leading George Bush into Iraq, it’s Mitt Romney trying to hand the country to his buddies at Bain Capital.

Working from this predetermined position, reporters are sure that Trump, who they think became president to fill the rooms in his D.C. hotel, isn’t merely peddling hope for hope’s sake alone.

All of this is just fodder for the screeching partisan minions, nothing else. If there were a healthy, functioning fourth column, a piece like this would never run. Can you imagine any major publication running a piece linking Barack Obama’s praise of GM’s heavily subsidized electric-car manufacturing to a thousand bucks in a mutual fund?

Nor should it escape your attention that the New York Times will assign four reporters to write an amateurish hit job, but not a single one to mention serious rape allegations against the leading Democratic Party p**********l candidate by a former staffer.

When Trump first mentioned hydroxychloroquine, reporters scoured the world to find overdose cases so they could claim the president had blood on his hands. When that effort came up short, they clutched pearls after some nitwit couple thought it wise to ingest fish-tank cleaning liquid. Now this.

Hydroxychloroquine is a prescription drug, not a pill that Americans can buy in bulk at the local Walmart and hoard in their closest and pop prophylactically each day. Media keeps asserting that Trump is “ignoring the experts.” Well, the president didn’t induce South Korean doctors to use hydroxychloroquine. He didn’t induce Indian doctors to use it. I assume American doctors who are now “off-labeling” the drug to patients have some medical reasons behind their thinking.

If doctors think it’s promising to look at it as a way to mitigate symptoms, why shouldn’t they go for it? It might help. It might not. Maybe another drug or treatment no one is talking about will emerge. There is nothing wrong with offering hope. Americans aren’t children, even if our media treats them as such.

(You don’t need to send me angry emails detailing all the downsides of championing potential drugs already in use for other diseases. One of my children takes hydroxychloroquine to help mitigate a dangerous autoimmune condition. I’ve already had to work hard to track down hydroxychloroquine because we live in a world with unethical hospitals and doctors who hoard it. Believe it or not, they’d still be doing it if the president hadn’t ever mentioned it, because they believe it holds promise.)
The Left’s Ugly Reaction to Hydroxychloroquine br ... (show quote)


Trump should have come out and said that opiates are effective for fighting the W***n Chinese v***s. The l*****ts would have gone bat $hit crazy and shut down all sales of the opiate market, it would be made illegal to take opiates and our drug crises would be over. No more opiates for the masses to help them overcome the c****a W***n Chinese v***s. The drug cartels would be going out of business and our National drug crises would have come to a screeching end. Trump could have used the same technique to end our addiction to alcohol. He could have said that beer and hard liquor help to eradicate the W***n v***s. The l*****ts would go nuts and stop all beer and hard liquor sales and our addiction to alcohol would end. Next up, tobacco. Trump could say tobacco usage cures the W***n v***s. L*****ts would go bat $hit crazy, prohibit anyone from smoking, chewing or sniffing tobacco and our addiction to tobacco and nicotine would end. L*****ts would want a double blind study and the studies would go on for 2 years. Those using tobacco products would be arrested and fined for not abiding by government protocols. Black Lies Matter Storm troopers and A****a thugs could go door to door and d**g tobacco users out of their homes and put them in quarantine. This could go on for years.

Reply
Apr 9, 2020 08:11:56   #
lindajoy Loc: right here with you....
 
eagleye13 wrote:
The Left’s Ugly Reaction to Hydroxychloroquine

‘While knee-jerk anti-Trumpism is expected, the angry obsession over the president’s championing of hydroxychloroquine is uniquely ugly.


For one thing, and I realize this might be difficult for some people to comprehend, it’s plausible, even likely, that Trump advocates for chloroquine because he is legitimately optimistic that a therapeutic answer might help Americans. Even if you feel he’s being reckless when speaking about the drug, you can accept that his intentions are good.


It’s also possible that Trump is hopeful about hydroxychloroquine because he thinks it will help his ree******n. Desiring an outcome that benefits the vast majority of Americans, but also benefits you, is a perfectly sound moral position. Hoping for negative outcomes to strengthen your partisan position, on the other hand, is pretty nefarious.


In any event, the crack team at the New York Times thinks it’s unfurled the mystery. “As of last year,” reports the paper, “Mr. Trump reported that his three family trusts each had investments in a Dodge & Cox mutual fund, whose largest holding was in Sanofi.”


As far as we know, Trump probably owns less than $100 of Sanofi stock in one of his mutual funds. If things go well, say he triples his position, Trump will be taking in upwards of $300. Art of the Deal, indeed.’



The Left’s Ugly Reaction to Hydroxychloroquine

David Harsanyi -- April 8, 2020


https://www.nationalreview.com/2020/04/the-lefts-ugly-reaction-to-hydroxychloroquine/

The idea that he is promoting the drug to boost the price of a mutual fund in which he owns shares is perhaps the most ludicrous conspiracy theory yet.

A widely shared, four-person-bylined, “wow”-provoking New York Times story today informs us that Donald Trump is personally benefiting from his “aggressive advocacy” of the anti-malaria drug hydroxychloroquine because he owns stock in one of the companies that manufacture the drug.

The story might be one of the most ridiculous articles published by mainstream media in the Trump era — though, admittedly, the field is highly competitive. But while knee-jerk anti-Trumpism is expected, the angry obsession over the president’s championing of hydroxychloroquine is uniquely ugly.

For one thing, and I realize this might be difficult for some people to comprehend, it’s plausible, even likely, that Trump advocates for chloroquine because he is legitimately optimistic that a therapeutic answer might help Americans. Even if you feel he’s being reckless when speaking about the drug, you can accept that his intentions are good.

It’s also possible that Trump is hopeful about hydroxychloroquine because he thinks it will help his ree******n. Desiring an outcome that benefits the vast majority of Americans, but also benefits you, is a perfectly sound moral position. Hoping for negative outcomes to strengthen your partisan position, on the other hand, is pretty nefarious.

In any event, the crack team at the New York Times thinks it’s unfurled the mystery. “As of last year,” reports the paper, “Mr. Trump reported that his three family trusts each had investments in a Dodge & Cox mutual fund, whose largest holding was in Sanofi.”

As far as we know, Trump probably owns less than $100 of Sanofi stock in one of his mutual funds. If things go well, say he triples his position, Trump will be taking in upwards of $300. Art of the Deal, indeed.

Though it’s unlikely. Sanofi is a French drugmaker that produces the hydroxychloroquine-label Plaquenil. The drug, however, isn’t patented, it isn’t particularly difficult to manufacture, and there are a bunch of giant pharma companies around the world already ramping up production of generic versions. Sanofi is less likely to benefit than Novartis or Bayer (check everyone’s mutual funds, pronto!).

So cunning is Trump’s scheme to spike his $1,000 mutual-fund position that he called India’s prime minister, Narendra Modi, this week and convinced him to lift a ban and start exporting even more generic hydroxychloroquine to the United States.

The Left simply can’t accept that a Republican acts in good faith. If they’re not hiding some devious self-serving motivation, they’re under the thumb of a foreign power or a shadowy industry. If it’s not Big Oil leading George Bush into Iraq, it’s Mitt Romney trying to hand the country to his buddies at Bain Capital.

Working from this predetermined position, reporters are sure that Trump, who they think became president to fill the rooms in his D.C. hotel, isn’t merely peddling hope for hope’s sake alone.

All of this is just fodder for the screeching partisan minions, nothing else. If there were a healthy, functioning fourth column, a piece like this would never run. Can you imagine any major publication running a piece linking Barack Obama’s praise of GM’s heavily subsidized electric-car manufacturing to a thousand bucks in a mutual fund?

Nor should it escape your attention that the New York Times will assign four reporters to write an amateurish hit job, but not a single one to mention serious rape allegations against the leading Democratic Party p**********l candidate by a former staffer.

When Trump first mentioned hydroxychloroquine, reporters scoured the world to find overdose cases so they could claim the president had blood on his hands. When that effort came up short, they clutched pearls after some nitwit couple thought it wise to ingest fish-tank cleaning liquid. Now this.

Hydroxychloroquine is a prescription drug, not a pill that Americans can buy in bulk at the local Walmart and hoard in their closest and pop prophylactically each day. Media keeps asserting that Trump is “ignoring the experts.” Well, the president didn’t induce South Korean doctors to use hydroxychloroquine. He didn’t induce Indian doctors to use it. I assume American doctors who are now “off-labeling” the drug to patients have some medical reasons behind their thinking.

If doctors think it’s promising to look at it as a way to mitigate symptoms, why shouldn’t they go for it? It might help. It might not. Maybe another drug or treatment no one is talking about will emerge. There is nothing wrong with offering hope. Americans aren’t children, even if our media treats them as such.

(You don’t need to send me angry emails detailing all the downsides of championing potential drugs already in use for other diseases. One of my children takes hydroxychloroquine to help mitigate a dangerous autoimmune condition. I’ve already had to work hard to track down hydroxychloroquine because we live in a world with unethical hospitals and doctors who hoard it. Believe it or not, they’d still be doing it if the president hadn’t ever mentioned it, because they believe it holds promise.)
The Left’s Ugly Reaction to Hydroxychloroquine br ... (show quote)


Unlike those Senators and Pelosi husband that sold off millions or bought other stocks right after a meeting ( inside trading) about the v***s I suppose, right??


Trump disclosed in his financial disclosure back in MAY his interest in a firm called Dodge & Cox called, cleverly enough, the Dodge & Cox International Stock Fund. Trump’s personal financial disclosure indicates that he holds shares in the fund through three different family trusts. The fund’s largest holding is, in fact, in Sanofi.
That said, only 3.3 percent of the fund’s holdings are in that company. What’s more, Trump’s disclosure, filed in May, shows that the three trusts each hold between $1,001 and $15,000 in the Dodge & Cox fund. In other words, Trump’s stake in Sanofi from each trust is between $33 and $495 — or between about $100 and $1,500 in total. However much he overstates his net worth, Trump is still worth nearly $3 billion, according to Bloomberg News, mostly as a function of the property...

owns..com/politics/2020/04/07/trumps-promotion-hydroxychloroquine-is-almost-certainly-about-politics-not-profits/%3foutputType=amp

Reply
Apr 9, 2020 09:26:25   #
Owl32 Loc: ARK
 
Liberty Tree wrote:
The left does not want a cure. They want more to die just so they can blame it on Trump.


Yes they do especially if they are TRUMP Supporters! The fear of hydroxycloroquine is just that the CRAZY left doing all they can to create a P******C but once again they fell short, Trump beat they at their own game and guess what they LOSE!

Reply
 
 
Apr 9, 2020 10:13:54   #
Big Kahuna
 
Owl32 wrote:
Yes they do especially if they are TRUMP Supporters! The fear of hydroxycloroquine is just that the CRAZY left doing all they can to create a P******C but once again they fell short, Trump beat they at their own game and guess what they LOSE!


Not only are the l*****ts and their pimps, the major media losing but now we even have a Detroit Democrat representative praising Trump for saving her life with Hydroxychloroquine when she was dying from the C****a W***n v***s. It just gets better for Trump the more the demonic left tries to harm him!!

Reply
Apr 9, 2020 11:13:36   #
kemmer
 
eagleye13 wrote:
The Left’s Ugly Reaction to Hydroxychloroquine

‘While knee-jerk anti-Trumpism is expected, the angry obsession over the president’s championing of hydroxychloroquine is uniquely ugly.


For one thing, and I realize this might be difficult for some people to comprehend, it’s plausible, even likely, that Trump advocates for chloroquine because he is legitimately optimistic that a therapeutic answer might help Americans. Even if you feel he’s being reckless when speaking about the drug, you can accept that his intentions are good.


It’s also possible that Trump is hopeful about hydroxychloroquine because he thinks it will help his ree******n. Desiring an outcome that benefits the vast majority of Americans, but also benefits you, is a perfectly sound moral position. Hoping for negative outcomes to strengthen your partisan position, on the other hand, is pretty nefarious.


In any event, the crack team at the New York Times thinks it’s unfurled the mystery. “As of last year,” reports the paper, “Mr. Trump reported that his three family trusts each had investments in a Dodge & Cox mutual fund, whose largest holding was in Sanofi.”


As far as we know, Trump probably owns less than $100 of Sanofi stock in one of his mutual funds. If things go well, say he triples his position, Trump will be taking in upwards of $300. Art of the Deal, indeed.’



The Left’s Ugly Reaction to Hydroxychloroquine

David Harsanyi -- April 8, 2020


https://www.nationalreview.com/2020/04/the-lefts-ugly-reaction-to-hydroxychloroquine/

The idea that he is promoting the drug to boost the price of a mutual fund in which he owns shares is perhaps the most ludicrous conspiracy theory yet.

A widely shared, four-person-bylined, “wow”-provoking New York Times story today informs us that Donald Trump is personally benefiting from his “aggressive advocacy” of the anti-malaria drug hydroxychloroquine because he owns stock in one of the companies that manufacture the drug.

The story might be one of the most ridiculous articles published by mainstream media in the Trump era — though, admittedly, the field is highly competitive. But while knee-jerk anti-Trumpism is expected, the angry obsession over the president’s championing of hydroxychloroquine is uniquely ugly.

For one thing, and I realize this might be difficult for some people to comprehend, it’s plausible, even likely, that Trump advocates for chloroquine because he is legitimately optimistic that a therapeutic answer might help Americans. Even if you feel he’s being reckless when speaking about the drug, you can accept that his intentions are good.

It’s also possible that Trump is hopeful about hydroxychloroquine because he thinks it will help his ree******n. Desiring an outcome that benefits the vast majority of Americans, but also benefits you, is a perfectly sound moral position. Hoping for negative outcomes to strengthen your partisan position, on the other hand, is pretty nefarious.

In any event, the crack team at the New York Times thinks it’s unfurled the mystery. “As of last year,” reports the paper, “Mr. Trump reported that his three family trusts each had investments in a Dodge & Cox mutual fund, whose largest holding was in Sanofi.”

As far as we know, Trump probably owns less than $100 of Sanofi stock in one of his mutual funds. If things go well, say he triples his position, Trump will be taking in upwards of $300. Art of the Deal, indeed.

Though it’s unlikely. Sanofi is a French drugmaker that produces the hydroxychloroquine-label Plaquenil. The drug, however, isn’t patented, it isn’t particularly difficult to manufacture, and there are a bunch of giant pharma companies around the world already ramping up production of generic versions. Sanofi is less likely to benefit than Novartis or Bayer (check everyone’s mutual funds, pronto!).

So cunning is Trump’s scheme to spike his $1,000 mutual-fund position that he called India’s prime minister, Narendra Modi, this week and convinced him to lift a ban and start exporting even more generic hydroxychloroquine to the United States.

The Left simply can’t accept that a Republican acts in good faith. If they’re not hiding some devious self-serving motivation, they’re under the thumb of a foreign power or a shadowy industry. If it’s not Big Oil leading George Bush into Iraq, it’s Mitt Romney trying to hand the country to his buddies at Bain Capital.

Working from this predetermined position, reporters are sure that Trump, who they think became president to fill the rooms in his D.C. hotel, isn’t merely peddling hope for hope’s sake alone.

All of this is just fodder for the screeching partisan minions, nothing else. If there were a healthy, functioning fourth column, a piece like this would never run. Can you imagine any major publication running a piece linking Barack Obama’s praise of GM’s heavily subsidized electric-car manufacturing to a thousand bucks in a mutual fund?

Nor should it escape your attention that the New York Times will assign four reporters to write an amateurish hit job, but not a single one to mention serious rape allegations against the leading Democratic Party p**********l candidate by a former staffer.

When Trump first mentioned hydroxychloroquine, reporters scoured the world to find overdose cases so they could claim the president had blood on his hands. When that effort came up short, they clutched pearls after some nitwit couple thought it wise to ingest fish-tank cleaning liquid. Now this.

Hydroxychloroquine is a prescription drug, not a pill that Americans can buy in bulk at the local Walmart and hoard in their closest and pop prophylactically each day. Media keeps asserting that Trump is “ignoring the experts.” Well, the president didn’t induce South Korean doctors to use hydroxychloroquine. He didn’t induce Indian doctors to use it. I assume American doctors who are now “off-labeling” the drug to patients have some medical reasons behind their thinking.

If doctors think it’s promising to look at it as a way to mitigate symptoms, why shouldn’t they go for it? It might help. It might not. Maybe another drug or treatment no one is talking about will emerge. There is nothing wrong with offering hope. Americans aren’t children, even if our media treats them as such.

(You don’t need to send me angry emails detailing all the downsides of championing potential drugs already in use for other diseases. One of my children takes hydroxychloroquine to help mitigate a dangerous autoimmune condition. I’ve already had to work hard to track down hydroxychloroquine because we live in a world with unethical hospitals and doctors who hoard it. Believe it or not, they’d still be doing it if the president hadn’t ever mentioned it, because they believe it holds promise.)
The Left’s Ugly Reaction to Hydroxychloroquine br ... (show quote)

All trumpish c***d ** sufferers should demand hydrooxychloroquine because Trump is invested in the company which makes it.

Reply
Apr 9, 2020 12:36:42   #
eagleye13 Loc: Fl
 
kemmer wrote:
All trumpish c***d ** sufferers should demand hydrooxychloroquine because Trump is invested in the company which makes it.


Kemmy; Do you have a death wish?
If Yes; swap spit with other Democrats
AND
stay away from, hydrooxychloroquine.

Reply
Apr 9, 2020 12:41:23   #
kemmer
 
eagleye13 wrote:

stay away from, hydrooxychloroquine.

That’s what Dr F***i has been saying.

Reply
Page 1 of 4 next> last>>
If you want to reply, then register here. Registration is free and your account is created instantly, so you can post right away.
Main
OnePoliticalPlaza.com - Forum
Copyright 2012-2024 IDF International Technologies, Inc.